Swedbank AB Sells 27,522 Shares of HCA Healthcare, Inc. $HCA

Swedbank AB reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 147,298 shares of the company’s stock after selling 27,522 shares during the period. Swedbank AB’s holdings in HCA Healthcare were worth $68,768,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Palisade Asset Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $31,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC bought a new stake in HCA Healthcare during the 4th quarter worth approximately $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have commented on the company. Leerink Partners decreased their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Robert W. Baird reduced their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Barclays reduced their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Sanford C. Bernstein reduced their target price on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a report on Tuesday, April 28th. Finally, Truist Financial reduced their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $517.82.

HCA Healthcare Trading Up 0.4%

Shares of NYSE HCA opened at $430.45 on Thursday. The stock has a fifty day simple moving average of $493.48 and a two-hundred day simple moving average of $486.55. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The firm has a market cap of $95.49 billion, a price-to-earnings ratio of 14.80, a price-to-earnings-growth ratio of 1.36 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. This trade represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,714 shares of company stock worth $7,050,460 over the last 90 days. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.